Kenneth Unuovurhaye, RN Registered Nurse - Community Health Medicare: Not Enrolled in Medicare Practice Location: 2073 Corners Circle Trce, Lithonia, GA 30058 Phone: 404-441-8139 |
Alicia Moore-herron, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2222 Cherokee Valley Cir, Lithonia, GA 30058 Phone: 404-849-6303 |
Bianca Rose Durant, Registered Nurse - School Medicare: Not Enrolled in Medicare Practice Location: 2801 Dekalb Medical Pkwy, Lithonia, GA 30058 Phone: 404-686-4411 |
Takiyah Jamila Rowe, CPNP,CNS,CPN Registered Nurse - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 7944 Harmony Lakes Dr, Lithonia, GA 30058 Phone: 404-819-8901 |
Ms. Valerie Denise Campbell, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 7033 Brecken Trce, Lithonia, GA 30058 Phone: 770-595-6102 |
Mrs. Pamela Odum Leonard, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2277 Stone Mountain Lithonia Rd, Lithonia, GA 30058 Phone: 770-484-2600 Fax: 770-484-0155 |
Roshni Patel, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2491 Panola Rd, Lithonia, GA 30058 Phone: 678-205-4999 |
Modupeola Ololade Fakunle, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 6987 Dalehollow Dr, Lithonia, GA 30058 Phone: 404-519-0373 |
Donnell Banks, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2053 Wellborn Rd, Lithonia, GA 30058 Phone: 770-742-6429 |
Dr. Brenda Muhoma, DNP, FNP, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 842 Louisa Ln, Lithonia, GA 30058 Phone: 209-225-5620 |
News Archive
Palbociclib, a new oral drug whose efficacy in combating breast cancer has been demonstrated alone and in combination with endocrine therapy, also has potential to combat other types of cancer, according to a literature review and additional original research conducted by experts at the Abramson Cancer Center in the University of Pennsylvania published this month in JAMA Oncology.
Revance Therapeutics, Inc. ("Revance") today announced the first $25 million closing of a $35 million Series D financing. The round was led by Essex Woodlands Health Ventures Fund VIII.
This post in the "Malaria Policy Center" blog describes a hearing of the House Foreign Affairs Subcommittee on Africa, Global Health, and Human Rights, titled "Fighting Malaria: Progress and Challenges," that was held on Monday.
Finding ways to help patients with COPD improve their functional status is an area of interest for pulmonary healthcare providers. Currently, pulmonary rehabilitation (PR) is used where available to improve exercise capacity and quality of life, but the treatment requires access to trained staff and specialized facilities.
The proteins that have now been identified shouldn't actually exist. Nevertheless, they build the core of cellular aggregates whose identity has been enigmatic until now. These aggregates are typically associated with hereditary neurodegenerative diseases including variants of frontotemporal dementia (FTD), also known as frontotemporal lobar degeneration (FTLD), and amyotrophic lateral sclerosis (ALS). They are likely to be damaging and might be a target for therapy.
› Verified 7 days ago